Journal of Inherited Metabolic Disease · 2018 · 33 citations · 11 references
Life SciencesNeurologyPediatricsMitochondrial BiologyPediatric NeurologyPediatric TherapeuticsMitochondrial DiseaseMitochondrial DisordersMitochondrial DysfunctionPediatric Clinical TrialsMitochondrial Myopathy EvaluationOutcome MeasuresOutcome Measures ValidationPediatric Natural HistoryValidation Study Design
Although there are no effective disease-modifying therapies for mitochondrial diseases, an increasing number of trials are being conducted in this rare disease group. The use of sensitive and valid endpoints is essential to test the effectiveness of potential treatments. There is no consensus on which outcome measures to use in children with mitochondrial disease. The aims of this two-day Delphi-based workshop were to (i) define the protocol for an international, multi-centre natural history study in children with mitochondrial myopathy and (ii) to select appropriate outcome measures for a validation study in children with mitochondrial encephalopathy. We suggest two sets of outcome measures for a natural history study in children with mitochondrial myopathy and for a proposed validation study in children with mitochondrial encephalopathy.
11
Prevalence of mitochondrial DNA disease in adults
Andrew M. Schaefer, Robert McFarland, Emma L. Blakely et al. · Annals of Neurology · 2007 · 582 citations
Neuroradiologic findings in children with mitochondrial disorders.
Leena Valanne, Leena Ketonen, Anna Majander et al. · PubMed · 1998 · 196 citations · Full text
Paul de Laat, Saskia Koene, Lambert P. W. J. den van Heuvel et al. · Journal of Inherited Metabolic Disease · 2012 · 143 citations · Full text